Home › Rectal Cancer › Michigan › Detroit
Rectal Cancer clinical trials in Detroit, MI
6 studies for Rectal Cancer are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Family Communications After Genetic Testing
RecruitingHealthy volunteers welcome
- Henry Ford Health Saint John Hospital, Detroit
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Henry Ford Health Saint John Hospital, Detroit
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
RecruitingPhase 1/2
- GSK Investigational Site, Detroit
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
RecruitingPhase 3
- Henry Ford Hospital, Detroit
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Recruiting
- Henry Ford Health System, Detroit
F-Tryptophan PET/CT in Human Cancers
RecruitingPhase 1
- Karmanos Cancer Institute, Detroit
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Columbus, OH10 studies
- Los Angeles, CA10 studies
- Tampa, FL9 studies
- Nashville, TN9 studies
- Seattle, WA9 studies
- Baldwin Park, CA8 studies
- Aurora, CO8 studies
- Salt Lake City, UT8 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.